The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells.
about
Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarineStructural Basis of Targeting the Exportin CRM1 in CancerNuclear export of proteins and drug resistance in cancerInhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agentsReduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.ABCG2 expression, function, and promoter methylation in human multiple myelomaPhase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with autologous stem cell transplant in refractory cancer: pharmacokinetic and pharmacodynamic correlatesRecent developments in cancer chemotherapy oriented towards new targets.Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitorsCRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo.Human multiple myeloma cells are sensitized to topoisomerase II inhibitors by CRM1 inhibition.Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer ProgressionUse of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.CRM1 Inhibitors for Antiviral Therapy.Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer.The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition.The catalytic subunit of Drosophila glutamate-cysteine ligase is a nucleocytoplasmic shuttling protein.
P2860
Q21284162-3DF4A99A-EDBB-464E-8CAF-3D5503C5BE0CQ26781513-597EA678-388C-4217-8E2D-2371BF01D711Q27012444-4D9FBE5D-B02B-4F0F-A509-9932A9CB52A3Q34410193-55017F74-242F-40E1-91D6-61C626C1BE52Q35488032-6A963170-B0E5-4064-821D-A17385FA871BQ35848835-7B62B2DF-9EAA-4734-9EEF-26C510EBC6A5Q35907089-1F5602ED-3046-49D5-A069-2B8F30B00904Q36150860-225A9BCE-46D4-4FB6-8330-A170757544ACQ36974685-DB47BAC6-5C0D-4C3E-B67B-2FA78257A88EQ37203487-93459D89-92FD-47ED-B710-6F013603C0CBQ37249490-47899176-B8A0-4A0E-ADCB-3A5C8A587B2AQ37347745-6E548337-478A-4D4E-80C8-41318739F492Q38820055-30B8DC12-D1C1-4134-86C8-1DBA30C445C8Q39040956-1851AE2B-BD58-41A1-ADBB-2E54F1B98A65Q39336778-7458E5DC-76E0-4611-82EB-B47A0678B6A9Q39431526-01605A30-7080-4490-BFB0-DA1CFDA8EE85Q40070852-70EC40A6-EB05-4386-B703-5336E527CB6EQ42128025-7D02151B-A4E7-4F40-891A-79837B73F2B0Q43195963-9C20408A-5665-4B9C-BF2C-206162DBCF04
P2860
The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The cytoplasmic trafficking of ...... stance in human myeloma cells.
@en
type
label
The cytoplasmic trafficking of ...... stance in human myeloma cells.
@en
prefLabel
The cytoplasmic trafficking of ...... stance in human myeloma cells.
@en
P2093
P1476
The cytoplasmic trafficking of ...... stance in human myeloma cells.
@en
P2093
Daniel M Sullivan
Jana L Gump
Lori Hazlehurst
Nikola I Valkov
Roxane Engel
William S Dalton
P304
P356
10.1016/J.YEXCR.2004.01.012
P407
P577
2004-05-01T00:00:00Z